Axsome Therapeutics Inc (AXSM)

[Frankestin]

Axsome is also working with the FDA to resolve chemistry, manufacturing, and controls issues with its regulatory submission for approval of AXS-07 in treating migraine. The company believes the issues are addressable and anticipates "an expeditious resubmission" of the New Drug Application.
Will it happen before AXS-05 is approved or after?
In my opinion first!